- Home
- VIR vs BXC Comparison
VIR vs BXC Comparison
Compare VIR & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- BXC
- Stock Information
- Founded
- VIR 2016
- BXC 2004
- Country
- VIR United States
- BXC United States
- Employees
- VIR N/A
- BXC N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- BXC Wholesale Distributors
- Sector
- VIR Health Care
- BXC Consumer Discretionary
- Exchange
- VIR Nasdaq
- BXC Nasdaq
- Market Cap
- VIR 706.4M
- BXC 551.4M
- IPO Year
- VIR 2019
- BXC 2004
- Fundamental
- Price
- VIR $5.65
- BXC $86.47
- Analyst Decision
- VIR Strong Buy
- BXC Strong Buy
- Analyst Count
- VIR 8
- BXC 5
- Target Price
- VIR $30.25
- BXC $115.40
- AVG Volume (30 Days)
- VIR 1.2M
- BXC 118.4K
- Earning Date
- VIR 07-31-2025
- BXC 07-29-2025
- Dividend Yield
- VIR N/A
- BXC N/A
- EPS Growth
- VIR N/A
- BXC N/A
- EPS
- VIR N/A
- BXC 4.53
- Revenue
- VIR $20,861,000.00
- BXC $2,935,514,000.00
- Revenue This Year
- VIR N/A
- BXC $3.40
- Revenue Next Year
- VIR $0.62
- BXC $5.01
- P/E Ratio
- VIR N/A
- BXC $18.92
- Revenue Growth
- VIR N/A
- BXC N/A
- 52 Week Low
- VIR $4.32
- BXC $63.14
- 52 Week High
- VIR $14.45
- BXC $134.79
- Technical
- Relative Strength Index (RSI)
- VIR 57.21
- BXC 68.81
- Support Level
- VIR $5.20
- BXC $80.42
- Resistance Level
- VIR $6.23
- BXC $88.30
- Average True Range (ATR)
- VIR 0.30
- BXC 3.48
- MACD
- VIR 0.07
- BXC 1.13
- Stochastic Oscillator
- VIR 56.06
- BXC 87.20
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.